This brand name is authorized in France, Singapore, South Africa, Spain, Tunisia.
The drug NAAXIA contains one active pharmaceutical ingredient (API):
1
|
N-acetyl aspartyl glutamic acid sodium salt
UNII
8A3Q9VKO7U - SPAGLUMATE SODIUM
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| S01GX03 | Spaglumic acid | S Sensory organs → S01 Ophthalmologicals → S01G Decongestants and antiallergics → S01GX Other antiallergics |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| ES | Centro de información online de medicamentos de la AEMPS | 60127 |
| FR | Base de données publique des médicaments | 60600334, 69171021 |
| SG | Health Sciences Authority | 11221P |
| TN | Direction de la Pharmacie et du Médicament | 8443011 |
| ZA | Health Products Regulatory Authority | 31/15.4/0109 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.